Ann E. Meyers

2.1k total citations
50 papers, 1.6k citations indexed

About

Ann E. Meyers is a scholar working on Biotechnology, Molecular Biology and Plant Science. According to data from OpenAlex, Ann E. Meyers has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Biotechnology, 18 papers in Molecular Biology and 18 papers in Plant Science. Recurrent topics in Ann E. Meyers's work include Transgenic Plants and Applications (28 papers), Plant Virus Research Studies (17 papers) and Vector-Borne Animal Diseases (14 papers). Ann E. Meyers is often cited by papers focused on Transgenic Plants and Applications (28 papers), Plant Virus Research Studies (17 papers) and Vector-Borne Animal Diseases (14 papers). Ann E. Meyers collaborates with scholars based in South Africa, United Kingdom and United States. Ann E. Meyers's co-authors include Edward P. Rybicki, Anna‐Lise Williamson, Inga I. Hitzeroth, Rosamund Chapman, Emmanuel Margolin, Enid Shephard, George P. Lomonossoff, Arkady F. Fradkov, Konstantin A. Lukyanov and Mikhail V. Matz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Ann E. Meyers

50 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann E. Meyers South Africa 23 847 656 354 339 301 50 1.6k
Loy E. Volkman United States 39 3.7k 4.4× 313 0.5× 423 1.2× 489 1.4× 138 0.5× 78 4.2k
Martin Blythe United Kingdom 25 1.4k 1.6× 139 0.2× 303 0.9× 334 1.0× 154 0.5× 42 1.9k
Martin Horn Czechia 27 930 1.1× 78 0.1× 228 0.6× 351 1.0× 234 0.8× 55 2.3k
Robert D. Possee United Kingdom 26 3.4k 4.0× 520 0.8× 264 0.7× 305 0.9× 154 0.5× 61 3.8k
Vitaly Boyko United States 24 779 0.9× 108 0.2× 198 0.6× 1.6k 4.8× 188 0.6× 31 2.4k
R. D. Possee United Kingdom 23 2.2k 2.6× 435 0.7× 250 0.7× 240 0.7× 212 0.7× 31 2.7k
Jörg Kinne United Arab Emirates 18 1.0k 1.2× 105 0.2× 448 1.3× 50 0.1× 170 0.6× 48 2.0k
Gary W. Blissard United States 42 4.6k 5.4× 515 0.8× 616 1.7× 614 1.8× 176 0.6× 82 5.3k
Olin Silander New Zealand 20 962 1.1× 42 0.1× 192 0.5× 240 0.7× 219 0.7× 37 1.9k
Pranav Danthi United States 23 578 0.7× 85 0.1× 322 0.9× 113 0.3× 1.2k 3.9× 54 1.8k

Countries citing papers authored by Ann E. Meyers

Since Specialization
Citations

This map shows the geographic impact of Ann E. Meyers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Meyers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Meyers more than expected).

Fields of papers citing papers by Ann E. Meyers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Meyers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Meyers. The network helps show where Ann E. Meyers may publish in the future.

Co-authorship network of co-authors of Ann E. Meyers

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Meyers. A scholar is included among the top collaborators of Ann E. Meyers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Meyers. Ann E. Meyers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lubisi, Baratang A., et al.. (2023). Chimaeric plant-produced bluetongue virus particles as potential vaccine candidates. Archives of Virology. 168(7). 179–179. 2 indexed citations
2.
Meyers, Ann E., et al.. (2022). Plant-Derived Human Vaccines: Recent Developments. BioDrugs. 36(5). 573–589. 33 indexed citations
3.
Chapman, Rosamund, Ann E. Meyers, Emmanuel Margolin, et al.. (2022). Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein. Nanotechnology. 33(48). 485102–485102. 6 indexed citations
4.
Margolin, Emmanuel, Rosamund Chapman, Ann E. Meyers, et al.. (2022). Investigating Constraints Along the Plant Secretory Pathway to Improve Production of a SARS-CoV-2 Spike Vaccine Candidate. Frontiers in Plant Science. 12. 798822–798822. 12 indexed citations
5.
Rybicki, Edward P., et al.. (2021). A Plant-Produced Virus-Like Particle Displaying Envelope Protein Domain III Elicits an Immune Response Against West Nile Virus in Mice. Frontiers in Plant Science. 12. 738619–738619. 23 indexed citations
6.
Margolin, Emmanuel, Yulia Meshcheriakova, Hadrien Peyret, et al.. (2020). Co‐expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants. Plant Biotechnology Journal. 18(10). 2109–2117. 49 indexed citations
7.
Chapman, Rosamund, Ann E. Meyers, Emmanuel Margolin, et al.. (2020). Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens. Frontiers in Bioengineering and Biotechnology. 8. 321–321. 5 indexed citations
8.
Margolin, Emmanuel, Richard Strasser, Rosamund Chapman, et al.. (2020). Engineering the Plant Secretory Pathway for the Production of Next-Generation Pharmaceuticals. Trends in biotechnology. 38(9). 1034–1044. 39 indexed citations
9.
10.
Meyers, Ann E., et al.. (2017). Therapeutic vaccines for high-risk HPV-associated diseases. Papillomavirus Research. 5. 46–58. 151 indexed citations
11.
Atkinson, Richard L., Felicity J. Burt, Edward P. Rybicki, & Ann E. Meyers. (2016). Plant-produced Crimean-Congo haemorrhagic fever virus nucleoprotein for use in indirect ELISA. Journal of Virological Methods. 236. 170–177. 16 indexed citations
12.
Chapman, Rosamund, William Bourn, Enid Shephard, et al.. (2014). The Use of Directed Evolution to Create a Stable and Immunogenic Recombinant BCG Expressing a Modified HIV-1 Gag Antigen. PLoS ONE. 9(7). e103314–e103314. 10 indexed citations
13.
Thuenemann, Eva C., et al.. (2013). A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus‐like particles. Plant Biotechnology Journal. 11(7). 839–846. 106 indexed citations
14.
Thuenemann, Eva C., Paolo Lenzi, Andrew J. Love, et al.. (2013). The Use of Transient Expression Systems for the Rapid Production of Virus-like Particles in Plants. Current Pharmaceutical Design. 19(31). 5564–5573. 53 indexed citations
15.
Valley‐Omar, Ziyaad, Ann E. Meyers, Enid Shephard, Anna‐Lise Williamson, & Edward P. Rybicki. (2011). Abrogation of contaminating RNA activity in HIV-1 Gag VLPs. Virology Journal. 8(1). 462–462. 22 indexed citations
16.
Pillay, Sirika, Ann E. Meyers, Anna‐Lise Williamson, & Edward P. Rybicki. (2009). Optimization of chimeric HIV‐1 virus‐like particle production in a baculovirus‐insect cell expression system. Biotechnology Progress. 25(4). 1153–1160. 40 indexed citations
17.
18.
Meyers, Ann E., et al.. (2008). Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles. Virus Research. 133(2). 259–268. 23 indexed citations
19.
Meyers, Ann E., Ereck Chakauya, Enid Shephard, et al.. (2008). Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnology. 8(1). 53–53. 77 indexed citations
20.
Shagin, Dmitry A., Ekaterina V. Barsova, Yurii G. Yanushevich, et al.. (2004). GFP-like Proteins as Ubiquitous Metazoan Superfamily: Evolution of Functional Features and Structural Complexity. Molecular Biology and Evolution. 21(5). 841–850. 332 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Loy E. Volkman Breakdown of academic impact, for papers by Martin Blythe Breakdown of academic impact, for papers by Martin Horn Breakdown of academic impact, for papers by Robert D. Possee Breakdown of academic impact, for papers by Vitaly Boyko Breakdown of academic impact, for papers by R. D. Possee Breakdown of academic impact, for papers by Jörg Kinne Breakdown of academic impact, for papers by Gary W. Blissard Breakdown of academic impact, for papers by Olin Silander Breakdown of academic impact, for papers by Pranav Danthi
Rankless by CCL
2026